Phase 3 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older (any gender can apply)
- You must be willing to take part and have signed a consent form agreeing to join the study
- Your general health and ability to carry out daily activities must be rated as very good or fully active (confirm with trial site)
- Your doctors expect you to live for at least 2 more years
- You must have been diagnosed with bladder cancer that has grown into the muscle wall of the bladder but has not spread to other parts of the body, confirmed by both tissue sample and imaging scans
- You must have at least one area of cancer that can be measured and tracked using standard imaging guidelines
- Your kidneys, liver, heart, and other organs must be working well enough to take part in the trial
Who may not be able to join:
- You received any cancer treatment affecting the whole body within the 4 weeks before starting this trial
- You are still experiencing significant side effects from a previous cancer treatment that have not mostly cleared up
- You have, or are suspected to have, a lung condition where the lung tissue becomes inflamed and scarred (confirm with trial site)
- You have any active or known disease where your immune system attacks your own body
- You have a heart condition or heart-related symptoms that are not well managed or controlled
- You have been diagnosed with any other type of cancer
- You had a serious infection in the 28 days before your first dose of the trial treatment
- You have a history of a weakened immune system
- You received a live vaccine (a weakened form of a virus used for vaccination) within 28 days before your first dose of the trial treatment
- You had a major surgical procedure within 28 days before starting the trial treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0518-82342973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Phase II: pCR evaluated by researchers;; Phase III: EFS assessed by BICR；
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.